CHAPEL HILL, N.C.--(BUSINESS WIRE)--Cessation Therapeutics, Inc. (“Cessation”), a clinical-stage biotechnology company advancing biologics that target substances of abuse, today announced that the U.S ...
We believe UNP will likely make a bid for NSC, and we view the risk/reward to the upside given where NSC shares are currently trading ($276.66 as of close 7/18). Following the unsubstantiated WSJ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback